M&A in pharmaceutical industries on rising rumor.

Published: 2007-02-09 07:00:00

Updated: 2007-02-09 07:00:00

An M&A in the local pharmaceutical industries showed ever rising rumors these days in order to overcome impending environmental challenges stemming from the KORUS FTA, positive list system and massive transfers of drugs into non-NHI reimbursement schedules.

An insider of pharmaceutical industr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK